Detection of TFPI2 methylation in the serum of hepatocellular carcinoma patients.
about
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentialsDNA methylation: potential biomarker in Hepatocellular Carcinoma.Can TIE-2 expressing monocytes represent a novel marker for hepatocellular carcinoma?DNA markers in molecular diagnostics for hepatocellular carcinoma.Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis.Methylated DNA and microRNA in body fluids as biomarkers for cancer detection.Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) is a potential biomarker for hepatitis B Virus associated hepatocellular carcinoma.Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer.The CpG Dinucleotide Adjacent to a κB Site Affects NF-κB Function through Its Methylation.Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.The role of TFPI2 hypermethylation in the detection of gastric and colorectal cancer.Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
P2860
Q26824909-165869D9-A449-46F6-B7B1-8019D500BF57Q33617129-D0711720-8443-4476-948B-E09042078D1EQ34077177-AC930EC8-FAAE-4449-9B96-325938A309E4Q35781255-DB35BB0D-0840-41D3-99D1-32E51D51B9C2Q36009225-5CAE5383-E887-4AFC-89D2-9D2F4A8B264AQ36913739-B0969CA7-DFFE-4A8A-9391-7E7DC461FB90Q37242412-DD639DB3-476B-4578-B9B1-A306F9E211FAQ37488688-08D05B49-FA47-491D-B237-A8B152C2D1A0Q37708509-E1588D98-1BDD-4D57-94B7-C22D37460D44Q37729088-6DDE314D-AF7A-483C-9AB1-D9163E39607BQ38152782-064C105E-57E3-4120-A766-99A49D406AD0Q38554626-C0064FA7-E6A5-4CD7-BE2E-FC9339C4FBE4Q41447190-8696EC78-B642-4ABC-A191-3F8CB4827D67Q41505555-6C370260-2EE0-45FA-8421-35942A8C2715Q46123774-8B65A249-175B-4A1A-A673-55C0A417856AQ57161777-DD9B0E95-5678-4CEB-A6F0-97040BD77725
P2860
Detection of TFPI2 methylation in the serum of hepatocellular carcinoma patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Detection of TFPI2 methylation in the serum of hepatocellular carcinoma patients.
@en
Detection of TFPI2 methylation in the serum of hepatocellular carcinoma patients.
@nl
type
label
Detection of TFPI2 methylation in the serum of hepatocellular carcinoma patients.
@en
Detection of TFPI2 methylation in the serum of hepatocellular carcinoma patients.
@nl
prefLabel
Detection of TFPI2 methylation in the serum of hepatocellular carcinoma patients.
@en
Detection of TFPI2 methylation in the serum of hepatocellular carcinoma patients.
@nl
P2093
P2860
P1476
Detection of TFPI2 methylation in the serum of hepatocellular carcinoma patients.
@en
P2093
Feng Zhang
Feng-Kai Sun
Yu-Chen Fan
Ze-Hua Zhao
P2860
P2888
P304
P356
10.1007/S10620-012-2462-3
P577
2012-10-31T00:00:00Z